Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Cash from Financing Activities (2020 - 2025)

Maravai Lifesciences Holdings has reported Cash from Financing Activities over the past 6 years, most recently at -$1.8 million for Q4 2025.

  • Quarterly results put Cash from Financing Activities at -$1.8 million for Q4 2025, up 99.23% from a year ago — trailing twelve months through Dec 2025 was -$16.5 million (up 93.0% YoY), and the annual figure for FY2025 was -$16.5 million, up 93.0%.
  • Cash from Financing Activities for Q4 2025 was -$1.8 million at Maravai Lifesciences Holdings, up from -$8.2 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for MRVI hit a ceiling of $809000.0 in Q3 2024 and a floor of -$236.2 million in Q4 2024.
  • Median Cash from Financing Activities over the past 5 years was -$21.6 million (2021), compared with a mean of -$33.0 million.
  • Biggest five-year swings in Cash from Financing Activities: soared 102.09% in 2023 and later tumbled 50352.98% in 2024.
  • Maravai Lifesciences Holdings' Cash from Financing Activities stood at -$49.6 million in 2021, then crashed by 33.37% to -$66.1 million in 2022, then skyrocketed by 100.71% to $470000.0 in 2023, then tumbled by 50352.98% to -$236.2 million in 2024, then surged by 99.23% to -$1.8 million in 2025.
  • The last three reported values for Cash from Financing Activities were -$1.8 million (Q4 2025), -$8.2 million (Q3 2025), and -$1.5 million (Q2 2025) per Business Quant data.